| Name | Title | Contact Details |
|---|
In 1990, Nitro Snowboards was founded by Thomas Delago and Sepp Ardelt in Seattle, Washington. Over the last 25 years Nitro has helped grow the sport of snowboarding through its groundbreaking product development, marketing, movies, grass roots events, and global team of world class snowboarders. Today Nitro has grown its product to offer all the essentials needed for having a good time snowboarding and traveling. Nitro´s headquarters are divided all over the world from the Mountains of Oberammergau, to the worlds best snow in Salt Lake City, UT, to the creative beaches of California, all the way up to the Northwest snowboarding destination of Vancouver, British Colombia. For more information visit us at http://www.nitrosnowboards.com or @NITROUSA on Instagram
In 2015, an important group of investors alongside a group of experienced professionals in the Reinsurance industry, acquired a majority interest in MBI Americas. Now, XS Global, a well-known regional MGA and Coverholder at Lloyds. The groups footprint and ambitions now encompass the underwriting space, utilizing strong synergies that exist between the groups core business strategy. Our unique structure provides us opportunities to deploy targeted reinsurance capacity both directly to corporates and to retail brokers via expert and locally based underwriters. We are proud to say we invest in talent and our team has proven skills, excellent access, and a proven track record for underwriting profitable business in the Latin America region and beyond.
Herspiegel is a consulting firm based in Pennsylvania, founded in 2007, that specializes in pharmaceutical and biotech commercialization services. With over fifteen years of experience, the company has supported more than 150 product launches across various therapeutic areas, including primary care, oncology, and rare diseases. Their mission is to create a model for successful pharmaceutical product launches. The firm offers a wide range of services tailored to the life sciences industry, including market access, medical affairs, marketing strategy, and operational execution. Herspiegels team consists of over 350 experts, including MDs, PhDs, MBAs, and pharmacists, who provide deep knowledge to help clients navigate complex challenges and maximize brand potential. They serve a diverse clientele, from startups to large global pharmaceutical companies, focusing on strategic insights and operational excellence to enhance commercial success and patient outcomes. Herspiegel has also expanded its capabilities through strategic acquisitions, such as Decisive Consulting, which enhances their market access and value strategy services. This positions Herspiegel to deliver innovative solutions in a dynamic pharmaceutical landscape.